PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Analyze analyst forecasts for the company and compare them with competitors.
42.82M
No peer data available for comparison.
-8.56M
No peer data available for comparison.
-0.59
No peer data available for comparison.
-17.89M
No peer data available for comparison.
-8.56M
No peer data available for comparison.
1.59B
No peer data available for comparison.
Analyze DCF forecasts for the company and compare them with competitors.
81.00K
No peer data available for comparison.
-92.14%
No peer data available for comparison.
-51.13M
No peer data available for comparison.
-63123.46%
No peer data available for comparison.
-51.92M
No peer data available for comparison.
-64098.77%
No peer data available for comparison.
790.00K
No peer data available for comparison.
76.68M
No peer data available for comparison.
94662.96%
No peer data available for comparison.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
7.95M
No peer data available for comparison.
9818.52%
No peer data available for comparison.
-153.00K
No peer data available for comparison.
-188.89%
No peer data available for comparison.
4.99%
No peer data available for comparison.
5.02%
No peer data available for comparison.
4.08%
No peer data available for comparison.
-0.23
No peer data available for comparison.
30.07M
No peer data available for comparison.
1.57M
No peer data available for comparison.
49.31M
No peer data available for comparison.
50.89M
No peer data available for comparison.
3.09%
No peer data available for comparison.
96.91%
No peer data available for comparison.
-51.92M
No peer data available for comparison.
-53.46M
No peer data available for comparison.
2.00%
No peer data available for comparison.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
-71.33M
No peer data available for comparison.
71.33M
No peer data available for comparison.
2.37
No peer data available for comparison.
View analysts' price targets and recommendations, and compare them with competitors.
$11.07
Analysts expect the stock price to increase by 521.91%.
Buy
Positive consensus among analysts.